Derma Sciences, Inc. Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2013. Highlights of the first quarter of 2013 and recent weeks include:
•Net sales of $18.8 million, up 23% over the prior-year first quarter; up 12% excluding sales from the April 2012 Total Contact Cast (TCC) acquisition
Help employers find you! Check out all the jobs and post your resume.
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2013. Highlights of the first quarter of 2013 and recent weeks include:
•Net sales of $18.8 million, up 23% over the prior-year first quarter; up 12% excluding sales from the April 2012 Total Contact Cast (TCC) acquisition
Help employers find you! Check out all the jobs and post your resume.